Telmisartan and Hydrochlorothiazide (Micardis HCT)
Telmisartan and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.
Questions a plan sponsor actually asks.
What is Telmisartan and Hydrochlorothiazide used for?
Telmisartan and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.
Is there a generic for Telmisartan and Hydrochlorothiazide?
Yes. 18 ANDAs filed at FDA, 6 generic manufacturers currently shipping.
How much does my plan pay for Telmisartan and Hydrochlorothiazide?
Across 329 Part D plans, Telmisartan and Hydrochlorothiazide averages $1.18/unit (NADAC). Lowest available: $0.349/unit. Highest in distribution: $4.48/unit.
Is Telmisartan and Hydrochlorothiazide on the FDA shortage list?
No. Telmisartan and Hydrochlorothiazide is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (15 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.